This happens when the blood supply to the bodys tissues is not properly oxygenated
[12] The approved dosing for both indications involves subcutaneous injection once weekly, with gradual dose escalation from 2.5 mg to maintenance doses of 5 mg, 10 mg, or 15 mg based on individual response and tolerability
Targets in the 1.2 to 1.6 grams per kilogram bodyweight range reduce muscle wasting and lower the chance of muscle weakness and soreness
Massey, Lerner Research Institute, Cleveland Clinic, United States Updates Copyright 2025 Karimi, Gholami Chahkand, Dadkhah, Sheikhzadeh, Yaghoubi, Esmaeilpour Moallem, Deyhimi, Arab Bafrani, Shahrokhi and Nasrollahizadeh